Related Experiment Video
Updated: May 28, 2026

06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
[MODY type diabetes: overview and recent findings]
Souhaïra Ben Khelifa1, Ilhem Barboura, Azza Dandana
1Laboratoire de biochimie, CHU Farhat Hached, Sousse, Tunisie. souhaira24@yahoo.fr
Annales De Biologie Clinique
|October 20, 2011
Summary
Maturity onset diabetes of the young (MODY) is a heterogeneous, monogenic diabetes. Recent advances clarify molecular causes and diagnostic strategies for this worldwide condition.
Area of Science:
- Endocrinology
- Genetics
- Molecular Biology
Context:
- Maturity onset diabetes of the young (MODY) is the most prevalent form of monogenic diabetes, characterized by autosomal dominant inheritance.
- It presents heterogeneously worldwide, typically diagnosed before 25 years of age and is non-ketotic.
- Despite significant progress, the full genetic landscape of MODY remains incompletely understood.
Purpose:
- To provide an updated overview of MODY, incorporating recent molecular discoveries and evolving diagnostic approaches.
- To consolidate current knowledge on the molecular basis, phenotypic variations, and epidemiological distribution of MODY subtypes.
- To highlight the ongoing need for further research to identify novel genetic factors associated with MODY X.
Summary:
- MODY is a genetically diverse condition with at least seven identified genes, though subtypes 2 and 3 are most common globally.
- Molecular abnormalities underlying MODY lead to varied phenotypic consequences, necessitating precise diagnostic strategies.
- Understanding the epidemiology and molecular diagnosis of each MODY subtype is crucial for optimizing patient care.
Impact:
- Enhanced understanding of MODY's genetic architecture facilitates more accurate diagnosis and personalized treatment strategies.
- This knowledge update aids clinicians in differentiating MODY from other diabetes types, improving patient management.
- Continued research into MODY genetics promises to uncover new therapeutic targets and diagnostic markers for rare diabetes forms.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
